Vascular Liver Disease Evaluation, Follow Up and Non-Invasive Diagnostics Program

Condition(s) studied

Investigational drug(s) / intervention(s)

no intervention: no intervention

Study summary

Background Vascular liver disorders (VALDI) are rare diseases, for which knowledge on risk factors, appropriate methods of diagnosis, effect of therapy and prognosis still need to be improved.

Aim of the study This project aims to study risk factors, methods of detection, therapy and prognosis in order to elaborate and disseminate updated recommendations for the optimal management of patients with VALDI.

Design of the study Data on patients will be collected from baseline (the date of diagnosis) up to 3 years. During this period, data on clinical condition, laboratory results, diagnostic tests, interventions and outcome will be collected anonymously using standardised review of medical charts by one special trained investigator. Only patients with VALDI are eligible to participate.

Eligibility

Primary outcome measure(s)

• Complications of Portal Hypertension — up to 3 years
  Ascites, Varices, Bleeding, Encephalpathy, Thrombosis

Trial sites (1)

More University Hospital, Bonn trials in Germany